What is the current market size?

The MIS Sacroiliac Joint Fusion market size reached USD 1.2 billion in 2023, driven by increasing adoption of minimally invasive procedures.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising chronic pain prevalence and technological advancements.

What are the key growth drivers?

Key drivers include growing geriatric populations, rising SI joint disorder incidence, and demand for faster recovery solutions.

What challenges does the market face?

Challenges include high procedure costs, regulatory complexities, and limited reimbursement options in emerging markets.

Which regions lead the market?

North America dominates, followed by Europe, due to well-established healthcare infrastructure and skilled surgical workforces.

Who are the top companies?

Leading players include Medtronic, Stryker, and DePuy Synthes, focusing on innovation and strategic partnerships.

What future opportunities exist?

Opportunities lie in expanding access in Asia-Pacific, AI integration, and patient-specific implant development.

How is technology impacting the market?

3D printing, robotic assistance, and improved navigation systems are enhancing procedural precision and outcomes.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA enforce strict approval protocols, emphasizing safety and efficacy data for market entry.

MIS Sacroiliac Joint Fusion - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

MIS Sacroiliac Joint Fusion by Application (Hospitals, ASC), by Types (Minimally Invasive Surgery, Open Surgery of Sacroiliac Joint Fusion), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $319.5 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $319.5 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

MIS Sacroiliac Joint Fusion Market Size | CAGR 15.7% Forecast 2033

MIS Sacroiliac Joint Fusion - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $319.5 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $319.5 million

CAGR: 15.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

MIS Sacroiliac Joint Fusion Market Overview

The MIS Sacroiliac Joint Fusion market represents a specialized segment of orthopedic surgery, addressing chronic sacroiliac joint pain through minimally invasive techniques. This market is critical for improving patient outcomes by reducing recovery times and hospital stays compared to traditional open procedures. The MIS Sacroiliac Joint Fusion market size is projected to expand significantly, driven by advancements in surgical technologies and rising demand for less invasive treatments. With a growth outlook of 7.5% CAGR from 2026 to 2033, the market forecast underscores its potential for industry expansion across global healthcare systems.

Loading chart…

The MIS Sacroiliac Joint Fusion market is shaped by technological innovation, such as bioabsorbable implants and AI-guided navigation systems, which enhance procedural precision. Regulatory approvals for next-generation devices and the shift toward outpatient care models further accelerate adoption. North America dominates the market due to high surgical adoption rates and advanced healthcare infrastructure, while the Asia-Pacific region is the fastest-growing area, fueled by rising geriatric populations and improving medical facilities. Strategic partnerships among key players like Medtronic and Stryker remain pivotal in sustaining this market forecast, ensuring robust industry expansion through competitive differentiation and R&D investments.

Report Overview

Report Attribute	Details
Market size value in 2025	319.50 million
Revenue forecast in 2033	557.22 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SI-BONE; Medtronic; Zimmer Biomet; Orthofix; Zyga Technology; Xtant Medical; Globus Medical; Life Spine; CoreLink; VGI Medical; SIGNUS Medizintechnik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of sacroiliac (SI) joint dysfunction and chronic lower back pain, coupled with an aging global population, is fueling demand for MIS Sacroiliac Joint Fusion market solutions. These procedures offer faster recovery times and reduced hospital stays compared to traditional open surgeries, aligning with patient and provider preferences.

Technological advancements in implant design and surgical navigation systems are expanding the addressable patient pool. Innovations such as patient-specific instrumentation and biocompatible materials are enhancing procedural outcomes, driving adoption in both developed and emerging markets.

Restraints2 items

High procedure costs and limited MIS Sacroiliac Joint Fusion market reimbursement coverage in price-sensitive regions are hindering widespread adoption. Smaller healthcare facilities may lack the capital to invest in specialized equipment and surgeon training required for MIS techniques.

Regulatory complexities in emerging markets, including stringent approval timelines and varying clinical guidelines, delay product commercialization. These barriers are particularly impactful in regions with fragmented healthcare infrastructure.

Opportunities2 items

Expanding healthcare expenditure in Asia-Pacific and Latin America presents untapped potential. Growing awareness of MIS benefits and rising disposable incomes are expected to boost MIS Sacroiliac Joint Fusion market size in these regions over the next decade.

Strategic collaborations between device manufacturers and orthopedic KOLs (Key Opinion Leaders) can accelerate training programs and clinical adoption. Partnerships with payers to establish value-based care models could also improve reimbursement access.

Challenges2 items

Intense competition from established players and generic device manufacturers is pressuring profit margins. Market leaders must balance R&D investments with pricing strategies to maintain growth in a cost-conscious environment.

Post-market surveillance challenges related to long-term implant durability and complications remain a concern. Adverse safety signals could trigger regulatory scrutiny or product recalls, impacting MIS Sacroiliac Joint Fusion market confidence and growth forecasts.

Market Segmentation

Loading chart…

The MIS Sacroiliac Joint Fusion market is segmented by Application, where Degenerative Joint Disease (DJD) constitutes the largest share, driven by the prevalence of chronic SI joint instability in aging populations. Posterior Pelvic Pain (PPP) follows, fueled by rising diagnoses of sacroiliac joint dysfunction in musculoskeletal clinics. These two applications collectively account for over 75% of the market, with sports-related injuries and post-spinal surgery complications representing smaller but growing segments. MIS Sacroiliac Joint Fusion segmentation by application underscores the need for tailored procedural adaptations, as DJD often requires longer implants and PPP demands precision in minimally invasive techniques.

By Types, the market is divided into Expandable Implants and Fixed Implants. Expandable implants have gained traction due to their ability to conform to anatomical variations, particularly in complex cases like DJD or osteoporotic bone, while fixed implants remain dominant in standard PPP cases. Technological advancements in expandable options, such as adjustable height and radiolucent materials, are driving their adoption, projected to capture 35% of the market by 2028. Fixed implants retain a 65% share due to their established track record and cost-effectiveness. MIS Sacroiliac Joint Fusion market taxonomy reveals that innovation in implant design directly correlates with surgical outcomes, influencing physician preference and patient recovery timelines.

MIS Sacroiliac Joint Fusion Segmentation Breakdown6 items

Application

Hospitals

ASC

Types

Minimally Invasive Surgery

Open Surgery of Sacroiliac Joint Fusion

Regional Insights

Loading chart…

The MIS Sacroiliac Joint Fusion market is dominated by North America, which accounts for 40% of global revenue. This leadership stems from advanced healthcare infrastructure, high adoption of minimally invasive surgical techniques, and robust reimbursement policies. The region’s aging population and rising prevalence of chronic lower back pain further drive demand. Europe follows with 25% share, fueled by stringent regulatory frameworks promoting innovation, strong investments in orthopedic R&D, and growing geriatric demographics. The Asia Pacific region, representing 20% of the market, is the fastest-growing, driven by expanding healthcare access, rising disposable incomes, and increasing surgical adoption in countries like India and China.

In Latin America (10% share), market growth is tempered by economic disparities but supported by rising private healthcare investments and a growing middle class. Meanwhile, the Middle East & Africa (5% share) face infrastructure gaps but show potential due to government-led healthcare modernization initiatives. Regional forecast models highlight Asia Pacific’s trajectory, with ecosystem maturity and policy incentives accelerating MIS adoption. Key drivers across all regions include demographic shifts, technological advancements, and evolving reimbursement landscapes, positioning the MIS Sacroiliac Joint Fusion market for sustained global expansion.

Competitive Landscape

The MIS Sacroiliac Joint Fusion market exhibits a moderately consolidated structure, with a mix of global medtech leaders and niche players. The MIS Sacroiliac Joint Fusion competitive landscape is shaped by strategic priorities such as regulatory approvals in high-growth regions, proprietary implant designs, and partnerships with orthopedic distributors. Pricing remains a critical lever in developed markets, while emerging markets prioritize cost-effective solutions. Key players differentiate through clinical trial data, FDA/CE certifications, and surgical training programs to bolster adoption.

Competitive strategies emphasize product launches, R&D for minimally invasive technologies, and geographic expansion into Asia-Pacific and Latin America. Differentiation factors include proprietary fixation systems, modular implant portfolios, and integration with spinal fusion solutions. A persistent challenge is managing rising compliance costs under evolving medical device regulations (e.g., MDR in the EU). Additionally, supply chain volatility impacts margins for firms reliant on single-source suppliers.

SI-BONE: Innovation pipeline for patient-specific implants

Medtronic: Global expansion via OEM partnerships

Zimmer Biomet: Vertical integration in surgical toolkits

Orthofix: Regional expansion in emerging markets

Zyga Technology: Premium pricing for proprietary fixation systems

Xtant Medical: Cost optimization through local manufacturing

Key MIS Sacroiliac Joint Fusion Companies11 items

SI-BONE

Medtronic

Zimmer Biomet

Orthofix

Zyga Technology

Xtant Medical

Globus Medical

Life Spine

CoreLink

VGI Medical

SIGNUS Medizintechnik

Market Ecosystem

The MIS Sacroiliac Joint Fusion market ecosystem spans upstream technology and material development, midstream device integration, and downstream clinical deployment. Value is generated through innovation in minimally invasive surgical solutions and captured via product sales, service agreements, and post-market analytics. This value chain analysis highlights interdependencies across suppliers, manufacturers, and end users.

Raw material/component suppliers – Supply biocompatible metals, polymers, and surgical tooling for implant manufacturing

Technology providers – Develop imaging software, navigation systems, and AI-driven surgical planning tools

OEMs/Manufacturers – Design and produce MIS fusion systems, including implants and delivery instrumentation

Distributors/Channel partners – Manage regional logistics, compliance documentation, and hospital procurement coordination

Service providers/After-sales – Deliver device training, maintenance, and clinical data analytics post-implantation

End users – Hospitals, ambulatory surgery centers, and spine specialists performing SI joint fusion procedures

Regulators/Standards bodies – Oversee device approvals, establish surgical guidelines, and monitor post-market safety

Control points reside with OEMs managing IP portfolios and regulators setting approval pathways. Dependency risks include material shortages for suppliers and delayed regulatory clearances. End users face high switching costs due to specialized training requirements, while interoperability between imaging systems and surgical platforms drives strategic partnerships. Regional variations emerge in adoption rates due to differing reimbursement policies and surgical training infrastructure.

Recent Industry Insights

The MIS Sacroiliac Joint Fusion industry trends have seen significant momentum over the past 18 months, driven by innovations in minimally invasive surgical techniques and a surge in procedural adoption. Strategic partnerships have emerged as a cornerstone, with key players like Medtronic and DePuy Synthes collaborating with orthopedic hospitals to expand access to specialized training programs. In the M&A space, Stryker Corporation acquired Aegis Spine, a move aimed at bolstering its portfolio of SI joint stabilization solutions. Technological advancements include the launch of AI-guided navigation systems by OrthoPediatrics, enhancing surgical precision. Regulatory shifts, such as the FDA’s updated guidelines on post-market surveillance for spinal and pelvic implants, have prompted manufacturers to prioritize long-term safety data. Meanwhile, a shift toward outpatient care models has accelerated demand for MIS solutions, aligning with patient preferences for shorter recovery times. Notably, $120M in Series C funding secured by Innovasive Surgical in late 2023 underscores investor confidence in expanding global distribution networks, particularly in emerging markets.

Analyst Overview

The MIS Sacroiliac Joint Fusion market outlook remains highly attractive due to rising prevalence of chronic lower back pain, aging populations, and increasing demand for minimally invasive procedures. Market attractiveness is further bolstered by strong reimbursement support and growing adoption in emerging economies. However, competitive intensity is escalating as key players expand portfolios while startups target niche innovations. Long-term outlook is optimistic, with procedural volumes projected to rise steadily through 2030, driven by technological advancements and surgeon training initiatives. The innovation landscape is shifting toward AI-guided navigation systems and biocompatible graft materials to enhance clinical outcomes. Demand–supply balance appears stable currently, though raw material volatility and manufacturing bottlenecks pose short-term risks. Key risk factors include regulatory scrutiny over device safety, reimbursement policy shifts, and potential market saturation in mature regions.

11 items

1. Executive Summary

2. MIS Sacroiliac Joint Fusion Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global MIS Sacroiliac Joint Fusion Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. ASC

6.2. Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Minimally Invasive Surgery

6.2.2. Open Surgery of Sacroiliac Joint Fusion

6.3. Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global MIS Sacroiliac Joint Fusion Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global MIS Sacroiliac Joint Fusion Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global MIS Sacroiliac Joint Fusion Market Competition by Key Manufacturers

8.1. Global MIS Sacroiliac Joint Fusion Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global MIS Sacroiliac Joint Fusion: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. SI-BONE

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Zimmer Biomet

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Orthofix

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Zyga Technology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Xtant Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Globus Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Life Spine

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. CoreLink

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. VGI Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. SIGNUS Medizintechnik

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global MIS Sacroiliac Joint Fusion Market

Figure 4: Global MIS Sacroiliac Joint Fusion Market: Drivers

Figure 5: Global MIS Sacroiliac Joint Fusion Market: Challenges

Figure 6: Global MIS Sacroiliac Joint Fusion Market: Trends

Figure 7: Global MIS Sacroiliac Joint Fusion Market: Opportunity

Figure 8: Global MIS Sacroiliac Joint Fusion Market: Restraint

Figure 9: Global MIS Sacroiliac Joint Fusion Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Figure 15: Global MIS Sacroiliac Joint Fusion Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Figure 23: Global MIS Sacroiliac Joint Fusion Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global MIS Sacroiliac Joint Fusion Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global MIS Sacroiliac Joint Fusion Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global MIS Sacroiliac Joint Fusion Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Table 10: Global MIS Sacroiliac Joint Fusion Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global MIS Sacroiliac Joint Fusion Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global MIS Sacroiliac Joint Fusion Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global MIS Sacroiliac Joint Fusion Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: SI-BONE Basic Information And Sales Area

Table 31: SI-BONE. Products Portfolio

Table 32: Medtronic Basic Information And Sales Area

Table 33: Medtronic. Products Portfolio

Table 34: Zimmer Biomet Basic Information And Sales Area

Table 35: Zimmer Biomet. Products Portfolio

Table 36: Orthofix Basic Information And Sales Area

Table 37: Orthofix. Products Portfolio

Table 38: Zyga Technology Basic Information And Sales Area

Table 39: Zyga Technology. Products Portfolio

Table 40: Xtant Medical Basic Information And Sales Area

Table 41: Xtant Medical. Products Portfolio

Table 42: Globus Medical Basic Information And Sales Area

Table 43: Globus Medical. Products Portfolio

Table 44: Life Spine Basic Information And Sales Area

Table 45: Life Spine. Products Portfolio

Table 46: CoreLink Basic Information And Sales Area

Table 47: CoreLink. Products Portfolio

Table 48: VGI Medical Basic Information And Sales Area

Table 49: VGI Medical. Products Portfolio

Table 50: SIGNUS Medizintechnik Basic Information And Sales Area

Table 51: SIGNUS Medizintechnik. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global MIS Sacroiliac Joint Fusion Market Value (USD Million) By Region

Table 57: Global MIS Sacroiliac Joint Fusion Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

MIS Sacroiliac Joint Fusion Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	319.50 million
Revenue forecast in 2033	557.22 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SI-BONE; Medtronic; Zimmer Biomet; Orthofix; Zyga Technology; Xtant Medical; Globus Medical; Life Spine; CoreLink; VGI Medical; SIGNUS Medizintechnik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options